Experience of the United Arab Emirates in the use of monoclonal antibody drug sotrovimab in high-risk vaccinated and unvaccinated patients with COVID-19: an observational cohort study

Experience of the United Arab Emirates in the use of monoclonal antibody drug sotrovimab in high-risk vaccinated and unvaccinated patients with COVID-19: an observational cohort study

Objectives Monoclonal antibodies can slow COVID-19 progression. This study describes the experience of using sotrovimab in patients with COVID-19 at high risk for disease progression and hospitalisation within the United Arab Emirates (UAE).Design Observational cohort study.Setting A tertiary hospit...

Full description

Bibliographic Details
Main Authors: Rami H. Al-Rifai, Sumaya Abdalateef, Noor Majed Al Meheiri, Mohamed Nassef, Ahmed A. Shorrab, Obaid Al Rahman Hashimi, Samah Allam, Mariam Saif Alnaqbi
Format: Article
Language:English
Published: BMJ Publishing Group 2023-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/1/e066095.full

Internet

https://bmjopen.bmj.com/content/13/1/e066095.full

Similar Items